Cargando…
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and ch...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528914/ https://www.ncbi.nlm.nih.gov/pubmed/36200122 http://dx.doi.org/10.2147/HMER.S377530 |
_version_ | 1784801391722627072 |
---|---|
author | Norcia, Luiz Fernando Watanabe, Erika Mayumi Hamamoto Filho, Pedro Tadao Hasimoto, Claudia Nishida Pelafsky, Leonardo de Oliveira, Walmar Kerche Sassaki, Ligia Yukie |
author_facet | Norcia, Luiz Fernando Watanabe, Erika Mayumi Hamamoto Filho, Pedro Tadao Hasimoto, Claudia Nishida Pelafsky, Leonardo de Oliveira, Walmar Kerche Sassaki, Ligia Yukie |
author_sort | Norcia, Luiz Fernando |
collection | PubMed |
description | Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2–5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality. |
format | Online Article Text |
id | pubmed-9528914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-95289142022-10-04 Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment Norcia, Luiz Fernando Watanabe, Erika Mayumi Hamamoto Filho, Pedro Tadao Hasimoto, Claudia Nishida Pelafsky, Leonardo de Oliveira, Walmar Kerche Sassaki, Ligia Yukie Hepat Med Review Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2–5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality. Dove 2022-09-29 /pmc/articles/PMC9528914/ /pubmed/36200122 http://dx.doi.org/10.2147/HMER.S377530 Text en © 2022 Norcia et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Norcia, Luiz Fernando Watanabe, Erika Mayumi Hamamoto Filho, Pedro Tadao Hasimoto, Claudia Nishida Pelafsky, Leonardo de Oliveira, Walmar Kerche Sassaki, Ligia Yukie Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment |
title | Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment |
title_full | Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment |
title_fullStr | Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment |
title_full_unstemmed | Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment |
title_short | Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment |
title_sort | polycystic liver disease: pathophysiology, diagnosis and treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528914/ https://www.ncbi.nlm.nih.gov/pubmed/36200122 http://dx.doi.org/10.2147/HMER.S377530 |
work_keys_str_mv | AT norcialuizfernando polycysticliverdiseasepathophysiologydiagnosisandtreatment AT watanabeerikamayumi polycysticliverdiseasepathophysiologydiagnosisandtreatment AT hamamotofilhopedrotadao polycysticliverdiseasepathophysiologydiagnosisandtreatment AT hasimotoclaudianishida polycysticliverdiseasepathophysiologydiagnosisandtreatment AT pelafskyleonardo polycysticliverdiseasepathophysiologydiagnosisandtreatment AT deoliveirawalmarkerche polycysticliverdiseasepathophysiologydiagnosisandtreatment AT sassakiligiayukie polycysticliverdiseasepathophysiologydiagnosisandtreatment |